Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy

Respiratory Care

Volumn 58, Issue 12, 2013, Pages 2076-2086

  Berlinski, Ariel ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

Albuterol; Children; Delivery device; Nebulizer; Tracheostomy

Indexed keywords

SALBUTAMOL;

ARTICLE; BREATHING PATTERN; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; INHALATION; MASK; NEBULIZATION; NEBULIZER; PARTICLE SIZE; SCHOOL CHILD; SIMULATOR; SPECTROPHOTOMETRY; TIDAL VOLUME; TRACHEOSTOMY; TRACHEOSTOMY TUBE;

ALBUTEROL; CHILDREN; DELIVERY DEVICE; NEBULIZER; TRACHEOSTOMY;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; CHILD; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; RESPIRATION; TRACHEOSTOMY;

EID: 84888114537     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02419     Document Type: Article

References (25)

1. Willis D, Berlinski A. Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care 2012; 57(8)1234-1241.
2. Amirav I, Newhouse MT. Aerosol therapy in tracheotomized children: time for guidelines! Respir Care 2012;57(8):1350.
3. O'Callaghan C, Dryden S, Cert DN, Gibbin K. Asthma therapy and a tracheostomy. J Laryngol Otol 1989;103(4):427-428.
4. Subhedar NV, Doyle C, Shaw NJ. Administration of inhaled medication via a tracheostomy in infants with chronic lung disease of prematurity. Pediatr Rehabil 1999;3(2):41-42.
5. Monksfield P. Modification of a spacer device for paediatric tracheostomy. Clin Otolaryngol 2008;33(2):193-194.
6. Webber PA, Brown AR. The use of a conical spacer after laryngectomy. BMJ (Clin Res Ed) 1984;288(6429):1537.
7. Nakhla V. A homemade modification of a spacer device for delivery of bronchodilator or steroid therapy in patients with tracheostomies. J Laryngol Otol 1997;111(4):363-365.
8. Mirza S, Hopkinson L, Malik TH, Willatt DJ. The use of inhalers in patients with tracheal stomas or tracheostomy tubes. J Laryngol Otol 1999;113(8):762-764.
9. Meeker DP, Stelmach K. Modification of the spacer device. Chest 1992;102(4):1243-1244.
10. García Pachón E, Casan P, Sanchís J. [Bronchodilators through tracheostomy]. Med Clin (Barc) 1992;99(10):396-397. Article in Spanish
11. Newhouse MT. Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: treatment with mask AeroChamber. Chest 1999;115(1):279-282.
12. Nandapalan V, Currey M, Jones TM. A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients. Clin Otolaryngol 2000;25(2):118-119.
13. Berlinski A, Chavez A. Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatric Pulmonology 2013;48(10):1026-1034.
14. Piccuito CM, Hess DR. Albuterol delivery via tracheostomy tube. Respir Care 2005;50(8):1071-1076.
15. Ari A, Harwood R, Sheard M, Fink JB. An in-vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care 2012;57(7):1066-1070.
16. Pitance I, Vecellio L, Delval G, Reychler G, Reychler H, Liistro G. Aerosol delivery through tracheostomy tubes: an in-vitro study. J Aerosol Med Pulm Drug Deliv 2013;26(2):76-83.
17. Berlinski A, Hayden JB. Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor. J Aerosol Med Pulm Drug Deliv 2010,23(6)397-404.
18. Barry PW, O'Callahan C. An in-vitro analysis of the output of salbutamol from different nebulizers. Eur Respir Care 1999;13(5): 1164-1169.
19. Chavez A, Holt S, Heulitt M, Berlinski A. Albuterol delivery via mdi/spacer in a spontaneously breathing pediatric tracheostomy model: does bagging improve drug delivery? (abstract) Am J Respir Crit Care Med 2011;183(Suppl):A3383.
20. Ahrens RC, Ries RA, Popendorf W, Wiese JA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol 1986;2(1):19-26.
21. Chavez A, McCraken A, Berlinski A. Effect of face mask static dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010;45(3):224-229.
22. Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, Le Souef PN. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7(12):185-191.
23. O'Riordan TG, Palmer LB, Smaldone GC. Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. AmJ Respir Crit Care Med 1994;149(1):214-219.
24. Berlinski A, Hayden J. Aerosol characteristics of 7% nebulized hypertonic saline delivered by 4 different nebulizers. Pediatr Pulmonol 2011;34(Suppl):336.
25. Fok TF, Al-Essa M, Monkman S, Dolovich M, Girard L, Coates G, Kirpalani H. Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits. Pediatr Res 1997;42(5):721-727.